Author

A. A. Slabikova

Observed names: A.A. Slabikova, Alexandra A. Slabikova, Alexandra А. Slabikova, Александра Алексеевна Слабикова, Слабикова А.А., Слабикова Александра Алексеевна

Institution: Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care"

Observed institutions: Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation, Medical Radiological Research Center, Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care"

ORCID: 0009-0001-7817-5180

Observed ORCID: 0009-0001-7817-5180

OpenAlex ID: A5115927380

Разработка и экспертная оценка мероприятий по совершенствованию организации медицинской помощи пациентам с онкологическими заболеваниями в субъектах Российской Федерации

2024 · Хайлова Ж.В., Омельяновский В.В., et al. · Бюллетень Национального научно-исследовательского института общественного здоровья имени Н. А. Семашко · 3

The relevance of clinical pharmacologists in providing medical care according to published studies

2026 · K.V. Gerasimova, V.V. Omelyanovsky, et al. · Clinical pharmacology and therapy · 1

PDF

International experience in the application of horizon scanning systems for identifying innovative health technologies

2025 · V. V. Omelyanovskiy, P. A. Mukhortova, et al. · Translational Medicine · 1

PDF

Approaches to reduce the uncertainty in the clinical efficacy of orphan drugs

2025 · V. V. Оmelyanovskiy, S. I. Kutsev, et al. · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · 1

PDF

Estimation of the socio-economic burden of obesity in the Russian Federation

2026 · L. Yu. Gorbachenko, K. I. Matrenin, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology

PDF

Pharmacoeconomic evaluation of follitropin alfa in patient groups with differential ovarian response in assisted reproductive technology programs

2026 · A. A. Slabikova, T. S. Teptsova, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology

Обзор подходов к проведению скрининга на болезнь Ниманна-Пика тип A/B, болезнь Помпе и мукополисахаридоз I типа

2026 · Сергей Владимирович Воронин, Виталий Владимирович Омельяновский, et al. · Бюллетень Национального научно-исследовательского института общественного здоровья имени Н. А. Семашко

PDF

Use of real‑world evidence in comprehensive drug assessment

2026 · F. V. Gorkavenko, V. V. Omelyanovskiy, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology

PDF

Clinical and economic consequences associated with expanding drug reimbursement for patients with chronic obstructive pulmonary disease

2026 · A.A. Slabikova, L.Yu. Gorbachenko, et al. · Medical Technologies Assessment and Choice

Review of international approaches to screening for Duchenne muscular dystrophy including neonatal screening programs

2026 · Sergey V. Voronin, Polina A. Mukhortova, et al. · L O Badalyan Neurological Journal

PDF

Evaluation of the clinical and economic feasibility of the use of certain adjuvant therapies in breast cancer treatment

2025 · K.I. Matrenin, T.S. Teptsova, et al. · Medical Technologies Assessment and Choice

The review of approaches to screening for spinal muscular atrophy in various countries

2025 · Sergey V. Voronin, Polina A. Mukhortova, et al. · L O Badalyan Neurological Journal

PDF

Overview of International Neonatal Screening Programs

2025 · Sergey V. Voronin, Vitaly V. Omelyanovskiy, et al. · Педиатрическая фармакология

PDF

Обзор международных программ неонатального скрининга

· Мухортова Полина Алексеевна, Воронин Сергей Владимирович, et al. · CyberLeninK (CyberLeninka)

Works count: 14

Citation count: 6

H-index: 1

I10-index: